[go: up one dir, main page]

DK1224188T3 - Sammensætning indeholdende methansulfonatsaltet af morfin og chitosan til nasal indgivelse - Google Patents

Sammensætning indeholdende methansulfonatsaltet af morfin og chitosan til nasal indgivelse

Info

Publication number
DK1224188T3
DK1224188T3 DK00969679T DK00969679T DK1224188T3 DK 1224188 T3 DK1224188 T3 DK 1224188T3 DK 00969679 T DK00969679 T DK 00969679T DK 00969679 T DK00969679 T DK 00969679T DK 1224188 T3 DK1224188 T3 DK 1224188T3
Authority
DK
Denmark
Prior art keywords
morphine
chitosan
composition containing
nasal administration
methanesulfonate salt
Prior art date
Application number
DK00969679T
Other languages
English (en)
Inventor
Lisbeth Illum
Alan Smith
Ian Lafferty
Peter Watts
Original Assignee
Archimedes Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimedes Dev Ltd filed Critical Archimedes Dev Ltd
Application granted granted Critical
Publication of DK1224188T3 publication Critical patent/DK1224188T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK00969679T 1999-10-20 2000-10-19 Sammensætning indeholdende methansulfonatsaltet af morfin og chitosan til nasal indgivelse DK1224188T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924797.5A GB9924797D0 (en) 1999-10-20 1999-10-20 Compound
PCT/GB2000/004003 WO2001029046A2 (en) 1999-10-20 2000-10-19 A salt of morphine

Publications (1)

Publication Number Publication Date
DK1224188T3 true DK1224188T3 (da) 2007-04-02

Family

ID=10863040

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969679T DK1224188T3 (da) 1999-10-20 2000-10-19 Sammensætning indeholdende methansulfonatsaltet af morfin og chitosan til nasal indgivelse

Country Status (15)

Country Link
US (1) US6387917B1 (da)
EP (1) EP1224188B1 (da)
JP (1) JP4928037B2 (da)
AU (1) AU771616B2 (da)
CA (1) CA2388395C (da)
CY (1) CY1106352T1 (da)
DE (1) DE60033044T2 (da)
DK (1) DK1224188T3 (da)
ES (1) ES2282141T3 (da)
GB (1) GB9924797D0 (da)
NO (1) NO327145B1 (da)
NZ (1) NZ518481A (da)
PT (1) PT1224188E (da)
WO (1) WO2001029046A2 (da)
ZA (1) ZA200203100B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
AU2004235744A1 (en) * 2003-05-01 2004-11-18 Archimedes Development Limited Nasal administration of the LH-RH analog leuprolide
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US20050129679A1 (en) 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
CN107260672A (zh) 2011-05-13 2017-10-20 欧洲凯尔特公司 包含纳洛酮的鼻内药物剂型
WO2014140899A2 (en) * 2013-03-15 2014-09-18 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB343397A (en) * 1929-05-24 1931-02-19 Chem Fab Vormals Sandoz Process for the manufacture of easily soluble salts of benzyl morphine
US2665227A (en) 1950-06-30 1954-01-05 Nat Res Corp Apparatus and method of coating by vapor deposition
CH407120A (de) * 1961-03-06 1966-02-15 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Piperidinderivaten
DE1445518A1 (de) * 1964-01-24 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Halogenallylpiperidinen
US4334071A (en) 1981-02-02 1982-06-08 Miles Laboratories, Inc. 17-Cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene-morphinane methanesulfonate
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
EP0689438B1 (en) * 1993-03-26 2003-06-04 Franciscus Wilhelmus Henricus Maria Merkus Pharmaceutical compositions for intranasal administration of apomorphine
ES2131083T3 (es) 1993-05-03 1999-07-16 Physion Srl Nuevas formulaciones de morfina para su utilizacion por administracion iontoforetica.
US5607940A (en) 1994-07-18 1997-03-04 Stephen; Robert L. Morphine formulations for use by electromotive administration
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
JPH09208465A (ja) 1996-02-07 1997-08-12 Takeda Chem Ind Ltd 高濃度注射用モルヒネ液
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
ES2174490T3 (es) 1997-09-25 2002-11-01 Lohmann Therapie Syst Lts Sales de adicion de acido de alcaloide de morfina y su utilizacion.
DE19834005A1 (de) * 1997-09-25 1999-04-01 Lohmann Therapie Syst Lts Säureadditionssalze von Morphin-Alkaloiden und deren Verwendung
KR20020016831A (ko) 1999-06-16 2002-03-06 나스텍 파마수티컬 컴퍼니 인코포레이티드 비내용 모르핀을 함유하는 의약 조성물 및 그 제조방법
WO2000076477A1 (en) 1999-06-16 2000-12-21 Nastech Pharmaceutical Co., Inc. Methods and compositions for treating breakthrough pain
AU6046900A (en) 1999-06-16 2001-01-02 Nastech Pharmaceutical Company, Inc Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate

Also Published As

Publication number Publication date
GB9924797D0 (en) 1999-12-22
EP1224188B1 (en) 2007-01-17
CY1106352T1 (el) 2011-10-12
NO20021815D0 (no) 2002-04-17
WO2001029046A3 (en) 2001-11-01
CA2388395A1 (en) 2001-04-26
AU771616B2 (en) 2004-04-01
JP2003512380A (ja) 2003-04-02
EP1224188A2 (en) 2002-07-24
PT1224188E (pt) 2007-02-28
NZ518481A (en) 2004-10-29
NO327145B1 (no) 2009-05-04
WO2001029046A2 (en) 2001-04-26
US6387917B1 (en) 2002-05-14
AU7933500A (en) 2001-04-30
DE60033044T2 (de) 2007-10-18
CA2388395C (en) 2010-03-09
DE60033044D1 (de) 2007-03-08
NO20021815L (no) 2002-06-14
ES2282141T3 (es) 2007-10-16
JP4928037B2 (ja) 2012-05-09
ZA200203100B (en) 2003-09-23

Similar Documents

Publication Publication Date Title
DK1035833T3 (da) Sammensætning til nasal indgivelse
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
FI991485L (fi) Uusi farmaseuttinen koostumus
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DE60020343D1 (de) Cilostazol enthaltende zubereitung
IS6310A (is) Kínasólínafleiður til lækninga
NO20015175D0 (no) Farmasöytisk sammensetning
IS6304A (is) Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
HUP0500870A3 (en) Nitrogen containing heterocyclic malanocortin receptor ligands, pharmaceutical compositions containing them and their use
FI19992171A7 (fi) Sprinkleri
DK1224188T3 (da) Sammensætning indeholdende methansulfonatsaltet af morfin og chitosan til nasal indgivelse
DE69941066D1 (de) Beatmungsgeräte
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20015510L (no) Medikament for lokal påföring
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
DE60021297D1 (de) Nasaler Dilatator
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed